DEDavid Ehlig

David Ehlig

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


David Ehlig has a total of 25 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Enhancing type 2 diabetes care by an individualized and group-based therapeutic patient education program: study protocol for a cluster randomized trial

    by David Ehlig, Maxime Sapin, Minette-Joëlle Zeukeng, Justus Vogel, Vincent Barthassat, Benoit Favre, Henrique DaCosta, Ksenia Tugay, Stephane Coendoz-Carron, David Bumann, et al.

    Background: Type 2 diabetes (T2D) presents a significant challenge to health systems and its prevalence is projected to increase. T2D is significantly influenced by lifestyle factors, including diet and physical activity. This makes therapeutic patient education (TPE) a pivotal component of T2D treatment strategies. While in some countries, like Germany and the UK, TPE elements like physician counselling regarding lifestyle changes (e.g., nutrition, smoking, exercise) and participation in diabetes education courses are part of structured nationwide disease management programs; in Switzerland, TPE elements are rarely part of the standard of care protocols. Our goal is to evaluate whether an interdisciplinary and individualized T2D program including TPE elements improves patients’ health outcomes. Methods: The study is a multi-center cluster randomized controlled trial in the canton of Geneva in Western Switzerland. We aim to include a minimum of 154 recently diagnosed T2D patients from around 30 primary care physician (PCP) practices. Practices are randomized with a 1:1 patient allocation ratio to either intervention or control group using covariate constrained randomization. The intervention lasts 12 months with a 6-month follow-up and consists of two steps. First, PCPs in the intervention group and associated healthcare professionals (e.g., dieticians, physical therapists) are trained in interprofessional group sessions on TPE elements by specialists. Second, patients follow an individualized treatment plan which is designed within an initial quality circle with their PCP, other healthcare professionals, a TPE specialist, a dedicated study manager, and other patients. The treatment plan is accompanied by regular patient-reported outcome measure (PROM) collections, which are discussed in patients’ regular PCP visits. Patients in the control group follow standard of care. Primary endpoint is the 12 months mean change in HbA1c levels, secondary endpoints are the 18 months mean change in HbA1c levels, the 12 and 18 months mean changes in patient-reported outcomes (EQ-5D-5L, DIAB-Q), mean changes in medical outcomes (blood pressure, body composition, medication intake), and patient experience. We further evaluate cost-effectiveness from the payer perspective. Discussion: A positive evaluation of the study can inform a wider roll-out of the T2D program within Switzerland and be a cornerstone for better patient health outcomes for T2D patients. Trial registration: ClinicalTrials.gov: NCT06774950. Registered on 14 January 2025

  • Open Access

    PROM-based monitoring and alerts reduce post-surgery healthcare utilization of patients undergoing joint replacement: A secondary analysis of the PROMoting Quality RCT

    by David Ehlig, Lukas Schöner, Alexander Geissler, Laura Wittich, Reinhard Busse, Justus Vogel

    Objectives: Healthcare systems increasingly face shortages of medical professionals, and simultaneously experience a rise in demand for healthcare services. In this study, we investigated whether a digital PROM-based monitoring and alert system for hip and knee replacement patients post-surgery can support in decreasing healthcare expenditures and utilization. Methods: We used data from the randomized controlled trial PROMoting Quality , focusing on 546 hip and 492 knee replacement patients from nine German hospitals between October 2019 and December 2020 with available claims data. Patients were equally randomized into two groups: one receiving a PROM-based intervention at 1, 3, and 6 months post-surgery, the other receiving standard care. We compared 1-year post-surgery healthcare utilization using mixed-effects regression models. We further extrapolated the intervention effects to the German healthcare system. Findings: Results showed post-surgery health expenditure reductions of 7.9% (-318.08, p = 0.015) for hip and 7.3% (-386.72, p = 0.053) for knee replacements. Significant decreases were observed in outpatient care contacts (-1.51, p = 0.005), physiotherapy sessions (-1.65, p = 0.037), and number of prescriptions (-2.14, p = 0.042) for hip replacements. For knee replacement patients, significant determinants of the cost differences were fewer prescriptions (-3.40, p = 0.013) and medical aids (-0.81, p = 0.041). Conclusion: Our findings suggest that digital health interventions can reduce utilization and save scarce healthcare resources. It can be hypothesized that the “being taken care of” effect reduced the need for reassurance of the recovery progress, leading to fewer GP visits and decreased utilization of other healthcare services.


  • Open Access

    Correction to: Digital Maturity Data: Extracting Insights for Health System Management

    by Justus Vogel, Johannes Hollenbach, Alexander Haering, David Ehlig, Alexander Geissler

  • Digital Maturity Data: Extracting Insights for Health System Management

    by Justus Vogel, Johannes Hollenbach, Alexander Haering, David Ehlig, Alexander Geissler

  • Open Access

    Risk factors for interval breast cancer: insights from a decade of a mammography screening program

    by Jonas Subelack, Rudolf Morant, Marcel Blum, Alena Eichenberger, Alexander Geissler, David Ehlig

    Purpose: Breast cancer remains a major global health issue, with mammography screening programs (MSPs) being critical for early detection to improve survival. Interval breast cancers (IBC) are an important quality criterion and have been linked with increased mortality. We aimed to identify risk factors for IBC diagnoses, based on MSP data. Methods: In this retrospective cohort study, we merged data from the Swiss MSP “donna” with data from cancer registries from 2010 to 2019 to categorize cases as IBC or screen-detected breast cancer (SBC). We compared the incidence, tumor characteristics, and survival proportions of women with IBC versus SBC. We used a multivariable Poisson regression with robust errors to identify risk factors for IBC diagnoses. Results: We identified 1134 breast cancer cases, specifically 251 IBC and 883 SBC. The 7-year survival proportions significantly deviated with 92.9% for women with IBC and 96.4% for women with SBC (p < 0.05). Women with IBC are diagnosed with significantly higher tumor stages (p < 0.05) and have a worse tumor biology in multiple dimensions e.g. larger tumor size or more often triple negative (p < 0.05). Higher breast density (BI-RADS d risk ratio (RR): 3.293), certain age groups (55–59 years RR: 1.345), and a family breast cancer history (RR: 1.299) were identified as significant (p < 0.05) risk factors for IBC diagnoses. Conclusions: Women with IBC had lower overall survival proportions than women with SBC, possibly due to higher stages at diagnosis. Increased breast density and a positive family history of breast cancer could encourage MSPs to personalize their screening process (e.g. additional diagnostics).